Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.3 - $1.87 $19,370 - $27,863
14,900 New
14,900 $20,000
Q3 2022

Nov 14, 2022

SELL
$2.1 - $2.73 $70,980 - $92,274
-33,800 Reduced 61.57%
21,100 $47,000
Q2 2022

Aug 15, 2022

SELL
$2.0 - $3.0 $1,600 - $2,400
-800 Reduced 1.44%
54,900 $114,000
Q1 2022

May 16, 2022

BUY
$2.9 - $3.47 $33,640 - $40,252
11,600 Added 26.3%
55,700 $162,000
Q4 2021

Feb 14, 2022

BUY
$3.17 - $4.09 $41,527 - $53,579
13,100 Added 42.26%
44,100 $142,000
Q3 2021

Nov 15, 2021

SELL
$3.01 - $3.77 $58,393 - $73,138
-19,400 Reduced 38.49%
31,000 $110,000
Q2 2021

Aug 11, 2021

SELL
$2.86 - $3.61 $24,596 - $31,046
-8,600 Reduced 14.58%
50,400 $160,000
Q1 2021

May 17, 2021

BUY
$2.61 - $4.08 $58,986 - $92,208
22,600 Added 62.09%
59,000 $203,000
Q4 2020

Feb 16, 2021

BUY
$1.82 - $2.61 $34,398 - $49,329
18,900 Added 108.0%
36,400 $92,000
Q3 2020

Nov 16, 2020

SELL
$2.02 - $3.02 $3,232 - $4,832
-1,600 Reduced 8.38%
17,500 $37,000
Q2 2020

Aug 14, 2020

BUY
$2.12 - $3.22 $17,596 - $26,726
8,300 Added 76.85%
19,100 $43,000
Q1 2020

May 15, 2020

BUY
$1.82 - $3.87 $19,656 - $41,796
10,800 New
10,800 $27,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $52.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.